Company profile
PRECLIN Biosystems SA
Preclin Biosystems AG offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics.
Source: startup.ch
More news about PRECLIN Biosystems SA
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
